Header Logo

Connection

ROBERT KRANCE to CD40 Ligand

Back to Details
This is a "connection" page, showing publications ROBERT KRANCE has written about CD40 Ligand.
ROBERT KRANCE
Connection Strength
0.059
CD40 Ligand
  1. Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation. Blood. 2006 Feb 15; 107(4):1332-41.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.